Published in Proc Natl Acad Sci U S A on November 01, 1987
Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest (1994) 1.30
Glutathione synthesis and turnover in the human erythrocyte: alignment of a model based on detailed enzyme kinetics with experimental data. J Biol Chem (2010) 1.08
Evolution of enzymes in a series is driven by dissimilar functional demands. Proc Natl Acad Sci U S A (2006) 0.90
Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol (1974) 5.46
The removal of leukocytes and platelets from whole blood. J Lab Clin Med (1976) 3.97
Glutathione transferase (human placenta). Methods Enzymol (1981) 3.59
Plasma membrane: rapid isolation and exposure of the cytoplasmic surface by use of positively charged beads. Science (1977) 1.64
The metabolic behavior of reduced glutathione in human and avian erythrocytes. J Biol Chem (1955) 1.56
The transport of oxidized glutathione from human erythrocytes. J Biol Chem (1969) 1.55
Synthesis and characterization of the L-cysteine-glutathione mixed disulfide. Acta Chem Scand (1967) 1.19
Glutathione transport by inside-out vesicles from human erythrocytes. Proc Natl Acad Sci U S A (1980) 1.09
Transport accounts for glutathione turnover in human erythrocytes. Blood (1979) 1.01
Demonstration and partial characterization of glutathione disulfide-stimulated ATPase activity in the plasma membrane fraction from rat hepatocytes. J Biol Chem (1985) 0.94
Studies on glutathione transport utilizing inside-out vesicles prepared from human erythrocytes. Biochim Biophys Acta (1981) 0.89
Active transport of GSSG from reconstituted erythrocyte ghosts. Blood (1975) 0.89
Glutathione S-conjugate transport using inside-out vesicles from human erythrocytes. Eur J Biochem (1982) 0.85
A simple, rapid, efficient method for the preparation of gamma 32P-labeled guanosine triphosphate (GTP) and adenosine triphosphate (ATP). J Lab Clin Med (1976) 0.84
Guanosine triphosphatase activity in human erythrocyte membranes. Biochim Biophys Acta (1980) 0.81
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
The removal of leukocytes and platelets from whole blood. J Lab Clin Med (1976) 3.97
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med (1994) 3.94
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J Immunol (1996) 3.45
Cladribine in treatment of chronic progressive multiple sclerosis. Lancet (1994) 3.25
Identification of human cancers deficient in antigen processing. J Exp Med (1993) 3.21
The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics (1989) 3.10
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med (1996) 2.99
Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol (1992) 2.83
Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A (1985) 2.82
A simple spot screening test for galactosemia. J Lab Clin Med (1966) 2.78
Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res (1994) 2.74
Tumor angiogenesis in human lung adenocarcinoma. Cancer (1994) 2.59
Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med (1995) 2.54
The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci U S A (1994) 2.48
In vivo behaviour of human muscle tendon during walking. Proc Biol Sci (2001) 2.42
Drug-induced hemolytic anemia. Pharmacol Rev (1969) 2.40
Hazards of indiscriminate screening for sickling. N Engl J Med (1971) 2.38
Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet (1994) 2.34
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med (1996) 2.31
Improved method for measuring galactose-I-phosphate uridyl transferase activity of erythrocytes. Clin Chim Acta (1966) 2.19
Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol (2000) 2.14
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med (1970) 2.12
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst (1996) 2.11
Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem (1995) 2.09
Electrophoresis of phosphoglycerate kinase. Biochem Genet (1969) 2.04
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet (2000) 2.02
International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol (1977) 2.01
Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood (1968) 1.99
The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol (1995) 1.99
Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med (1998) 1.99
A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med (1992) 1.98
Detection of the defect of Gaucher's disease and its carrier state in peripheral-blood leucocytes. Lancet (1970) 1.98
Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet (1989) 1.97
Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell (1995) 1.96
Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) (1992) 1.96
Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood (1994) 1.94
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci U S A (1994) 1.91
Molecular characterization of defective antigen processing in human prostate cancer. J Natl Cancer Inst (1995) 1.90
Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med (1996) 1.86
Human transferrin G277S mutation: a risk factor for iron deficiency anaemia. Br J Haematol (2001) 1.86
High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet (1991) 1.81
Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect (2000) 1.80
Muscle volume is a major determinant of joint torque in humans. Acta Physiol Scand (2001) 1.78
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem (1994) 1.76
Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood (1968) 1.74
Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA (1998) 1.73
Determination of fascicle length and pennation in a contracting human muscle in vivo. J Appl Physiol (1985) (1997) 1.73
A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood (1966) 1.73
Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood (1992) 1.72
Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci U S A (1988) 1.72
Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res (1998) 1.72
Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem (2000) 1.72
International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol (1979) 1.71
Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood (1997) 1.71
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci U S A (1994) 1.70
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med (1999) 1.69
Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann Rheum Dis (2001) 1.68
Measurement of viscoelastic properties of tendon structures in vivo. Scand J Med Sci Sports (2002) 1.66
The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis (1998) 1.65
2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol (1992) 1.65
Acquisition of transforming properties by FYN, a normal SRC-related human gene. Proc Natl Acad Sci U S A (1988) 1.60
Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease. Nature (1973) 1.60
Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy (2000) 1.59
Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol (1990) 1.57
Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. Am J Hum Genet (1971) 1.56
The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest (2001) 1.56
Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N Engl J Med (1967) 1.56
The transport of oxidized glutathione from human erythrocytes. J Biol Chem (1969) 1.55
Human tumor antigens recognized by T cells. Curr Opin Immunol (1996) 1.54
Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene. Proc Natl Acad Sci U S A (1985) 1.53
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes (1995) 1.51
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest (1993) 1.51
Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. Cancer Res (2001) 1.50
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) (2005) 1.50
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A (1997) 1.48
Mucous gland adenoma of the trachea resected with an endoscopic neodymium: yttrium aluminum garnet laser. Intern Med (1996) 1.48
Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. J Immunol (1983) 1.48
Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med (1998) 1.48
Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem (1975) 1.48
Cross-reacting material in Gaucher disease fibroblasts. Proc Natl Acad Sci U S A (1984) 1.47
Regulation of B cell differentiation by T cell subsets defined with monoclonal OKT4 and OKT8 antibodies in human cord blood. J Immunol (1981) 1.46
Studies on human beta-D-N-acetylhexosaminidases. 3. Biochemical genetics of Tay-Sachs and Sandhoff's diseases. J Biol Chem (1974) 1.46
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res (1995) 1.45
Leucocytosis as a marker of organ damage induced by chronic strenuous physical exercise. Eur J Appl Physiol Occup Physiol (1995) 1.45
Studies on human beta-D-N-acetylhexosaminidases. I. Purification and properties. J Biol Chem (1974) 1.44
A comparison of two neurologic scoring instruments for multiple sclerosis. J Neurol (1996) 1.44
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A (1995) 1.44
Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem (1996) 1.44
Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J Immunol (1997) 1.43
Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med (1971) 1.43
Prevalence of depressive symptoms in a Japanese occupational setting: a preliminary study. Am J Public Health (1989) 1.42
Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res (2000) 1.42
Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity. Biochem Biophys Res Commun (1976) 1.42
Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan. J Epidemiol (1996) 1.42
Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia (2001) 1.41
Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J (1996) 1.41